Download free PDF

Demulcent Eye Drops Market Size & Share 2022 to 2030

Market Size by Active Pharmaceutical Ingredient Type (Cellulose Derivatives, Dextran 70, Polyols, Polymers), by Drug formulation (Preservative Based, Non-Preservative Based), Medication Type, Distribution Channel & Forecast.

Report ID: GMI5351
   |
Published Date: September 2022
 | 
Report Format: PDF

Download Free PDF

Demulcent Eye Drops Market Size

Demulcent Eye Drops Market size was worth more than USD 1.8 billion in 2021 and is expected to grow at a CAGR of more than 6% through 2030. Easy product accessibility and increased availability will push industry growth.

Demulcent Eye Drops Market

Growing cases of various eye disorders across the world is the primary factor propelling the market expansion. Recent data reveals that dry eye disease (DED) affects around 5% adult Americans. Notably, DED leads to numerous complications such as microaneurysm, optic nerve injury, and retinal thickness. Increase in instances of dry eye disease is one of the main factors that will boost demand for demulcent eye drops.  Additionally, higher pervasiveness of ocular ailments across developing nations, especially among geriatric population will augment the demulcent eye drops market outlook.
 

Demulcent Eye Drops Market Trends

One of the key factors preventing the business from growing is the fact that demulcent eye drops, which are readily available over-the-counter, have a variety of negative effects. These eye drops are preserved using ingredients including purite, EDTA, and BAK to maintain pH level of tear film. Excessive or incorrect usage of such medications may cause adverse reactions such as allergies and ocular toxicity. The looming chances of discontinuation of certain ocular eye drops with preservatives may restrain the market growth.
 

Demulcent Eye Drops Market Analysis

Demulcent Eye Drops Market , by API Type

The demulcent eye drops market is divided into polyols, dextran 70, polymers, cellulose derivatives, and others, based on active pharmaceutical ingredient types. The polyols segment crossed USD 550 million in 2021. The cases of digital eye strain is rising as a result of the growing usage of electronic gadgets. Furthermore, a notable rise in retinal diseases and eye treatments has stimulated segment share.
 

Depending on drug formulation, the demulcent eye drops market is segmented into preservative based and non-preservative-based products. The non-preservative-based segment is set to surpass USD 1 billion by 2030. Preservatives such as sodium chlorite, benzalkonium chloride (BAK), etc. are used in eye drop formulations which are harmful at times.
 

The non-preservative-based demulcent eye drops segment is expected to develop in the forthcoming years owing to consumer preference for product due to the growing awareness of the eye-health risks caused by preservatives.
 

The market is categorized into over the counter (OTC) and prescriptions, as per medication type. The OTC segment exceeded USD 1 billion in 2021. Over-the-counter medications are the ones that may be purchased without a prescription, ensuring easier access to pharmaceuticals. Increased availability and accessibility of demulcent eye drops to the general public through OTC is impelling the segment demand.
 

Demulcent Eye Drops Market, by Distribution Channel

In terms of distribution channel, worldwide demulcent eye drops market is categorized into retail pharmacies, online pharmacies, and hospital pharmacies. The retail pharmacies segment held more than 50% business share in 2021 and is projected to record significant growth rate over the study period. The availability of affordable demulcent eye drops at retail medical stores and the rising acceptance of over-the-counter products are giving push to the industry value.
 

Demulcent Eye Drops Market, By Region, 2021 ( USD Million)

Europe demulcent eye drops market is anticipated to surpass USD 875 million by 2030. This is due to growing elderly population base and the significant increase in the patients suffering from dry eye disease in the European nations. The product demand will soar in the coming years, resulting from the consequences of DED such as corneal ulcers, vision loss, and decreased quality of life.
 

Demulcent Eye Drops Market Share

Firms like

  • Johnson and Johnson Services Inc.
  • Alcon Inc.
  • OASIS Medical
  • Allegan (AbbVie Inc.)
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Bausch Health Companies Inc.
  • Aurolab
  • Otsuka Pharmaceutical Co.,Ltd.
  • Sentiss Pharma Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • URSAPHARM Arzneimittel GmbH

are the major competitors in the demulcent eye drops market.
 

In order to establish a strong market position, the manufacturers are strategically focusing on creating innovative solutions to meet the requirements of the customers. For instance, in January 2022, Systane Complete Preservative-Free Lubricant Eye Drops was made available in Europe by Alcon. This strategy widened Alcon's footprint in the massive and rapidly expanding artificial tears industry, generating sales worth over USD 1 billion annually.
 

Impact of COVID-19 Pandemic

The COVID-19 outbreak negatively affected almost every industry and organization, irrespective of size, plummeting the global economy. Due to the lack of both critical and non-essential medical supplies, there was a turmoil in the medical sector. The disruption of the supply chain impacted the production and shipping of demulcent eye drops, hampering the industry growth. However, growing sales of OTC demulcent eye drops, in tandem with shifting consumer preference for purchasing through online pharmacies will aid the global market to recover and grow in the coming years.
 

The demulcent eye drops market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030, for the following segments:

By Active Pharmaceutical Ingredient Type

  • Cellulose Derivatives
  • Dextran 70
  • Polyols
  • Polymers
  • Others

By Drug Formulation

  • Preservative Based
  • Non-Preservative Based

By Medication Type

  • Over-the-counter (OTC)
  • Prescription

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Others

 

Authors:  Monali Tayade, Jignesh Rawal

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the size of demulcent eye drops market?
The global market size for demulcent eye drop was valued at over USD 1.8 billion in 2021 and is predicted to rise at a CAGR of over 6% through 2030, owing to an increase in the incidence rate of eye ailments worldwide.
Why is polyols gaining popularity as active pharmaceutical ingredient?
The polyols segment was valued over USD 550 million in 2021 and will exhibit a significant growth during the forecast period, owing to its usage for treatment of digital eye strain, retinal diseases, and other eye conditions.
How will the non-preservative-based product segment expand through 2030?
The non-preservative-based formulation segment held a sizable market share in 2021 and is projected to surpass USD 1 billion by 2030, owing to its increasing usage resulting from growing awareness of the eye-health risks caused by preservatives.
Which are the leading companies in the demulcent eye drops industry?
Top enterprises such as Johnson and Johnson Services Inc., Alcon Inc., OASIS Medical, Allegan (AbbVie Inc.), Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co. Ltd., Bausch Health Companies Inc., Aurolab, and others form the competitive landscape of the global demulcent eye drops market.
Demulcent Eye Drops Market Scope
  • Demulcent Eye Drops Market Size

  • Demulcent Eye Drops Market Trends

  • Demulcent Eye Drops Market Analysis

  • Demulcent Eye Drops Market Share

Authors:  Monali Tayade, Jignesh Rawal
Explore Our Licensing Options:

Starting at: $2,450

Immediate Delivery Available

Premium Report Details:

Base Year: 2021

Companies Profiled: 12

Tables & Figures: 238

Countries Covered: 17

Pages: 240

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)